Ferro A - Search Results

1

Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer.

Ferro A, Campora M, Caldara A, De Lisi D, Lorenzi M, Monteverdi S, Mihai R, Bisio A, Dipasquale M, Caffo O, Ciribilli Y. Ferro A, et al. J Clin Med. 2024 Jun 20;13(12):3611. doi: 10.3390/jcm13123611. J Clin Med. 2024. PMID: 38930141 Free PMC article. Review.

2

Pain and quality of life after surgery for breast cancer.

Caffo O, Amichetti M, Ferro A, Lucenti A, Valduga F, Galligioni E. Caffo O, et al. Among authors: ferro a. Breast Cancer Res Treat. 2003 Jul;80(1):39-48. doi: 10.1023/A:1024435101619. Breast Cancer Res Treat. 2003. PMID: 12889597

3

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience.

Galligioni E, Berloffa F, Caffo O, Tonazzolli G, Ambrosini G, Valduga F, Eccher C, Ferro A, Forti S. Galligioni E, et al. Among authors: ferro a. Ann Oncol. 2009 Feb;20(2):349-52. doi: 10.1093/annonc/mdn567. Epub 2008 Aug 20. Ann Oncol. 2009. PMID: 18718889 Free article.

4

Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer.

Murgia V, Sorio R, Griso C, Caffo O, Arcuri C, Ferro A, Caldara A, Scalone S, Arisi E, Galligioni E. Murgia V, et al. Among authors: ferro a. Int J Gynecol Cancer. 2010 Aug;20(6):953-7. doi: 10.1111/IGC.0b013e3181e4a6c1. Int J Gynecol Cancer. 2010. PMID: 20683401 Clinical Trial.

5

Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: assessment of clinical outcomes and predictive factors.

Caffo O, Pappagallo G, Brugnara S, Caldara A, di Pasquale MC, Ferro A, Frisinghelli M, Murgia V, Russo LM, Soini B, Valduga F, Veccia A, Galligioni E. Caffo O, et al. Among authors: ferro a. Urology. 2012 Mar;79(3):644-9. doi: 10.1016/j.urology.2011.11.043. Urology. 2012. PMID: 22386418

6

PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy.

Barbareschi M, Cuorvo LV, Girlando S, Bragantini E, Eccher C, Leonardi E, Ferro A, Caldara A, Triolo R, Cantaloni C, Decarli N, Galligioni E, Dalla Palma P. Barbareschi M, et al. Among authors: ferro a. Virchows Arch. 2012 Aug;461(2):129-39. doi: 10.1007/s00428-012-1267-2. Epub 2012 Jun 29. Virchows Arch. 2012. PMID: 22744290

7

PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapy.

Cuorvo LV, Verderio P, Ciniselli CM, Girlando S, Decarli N, Leonardi E, Ferro A, Caldara A, Triolo R, Eccher C, Cantaloni C, Mauri F, Seckl M, Volante M, Buttitta F, Marchetti A, Silvia Q, Galligioni E, Palma PD, Barbareschi M. Cuorvo LV, et al. Among authors: ferro a. Virchows Arch. 2014 Jan;464(1):85-93. doi: 10.1007/s00428-013-1500-7. Virchows Arch. 2014. PMID: 24233241

8

Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre.

Dipasquale M, Murgia V, Veccia A, Brugnara S, Caldara A, Ferro A, Frisinghelli M, Maines F, Trentin C, Valduga F, Caffo O. Dipasquale M, et al. Among authors: ferro a. Anticancer Drugs. 2017 Jul;28(6):654-659. doi: 10.1097/CAD.0000000000000482. Anticancer Drugs. 2017. PMID: 28252532

9

Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution Experience.

Merz V, Ferro A, Piras EM, Zanutto A, Caffo O, Messina C. Merz V, et al. Among authors: ferro a. JCO Oncol Pract. 2021 Jan;17(1):e44-e52. doi: 10.1200/OP.20.00643. Epub 2020 Dec 22. JCO Oncol Pract. 2021. PMID: 33351674

10

Learning from organisational changes in the management of breast cancer patients during the COVID-19 pandemic: Preparing for a second wave at a breast unit in northern Italy.

Ferro A, Cristofolini P, Garcia-Etienne CA, Caffo O, Pellegrini M, Fantò C, Mussari S, Campregher M, Lazzeri S, Cantarelli S, Guarrera GM. Ferro A, et al. Int J Health Plann Manage. 2021 Jul;36(4):1030-1037. doi: 10.1002/hpm.3181. Epub 2021 Apr 22. Int J Health Plann Manage. 2021. PMID: 33890324 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,004 results

Search Page

Filters